The anticancer peptide RT53 induces immunogenic cell death

In recent years, immunogenic cell death (ICD) has emerged as a revolutionary concept in the development of novel anticancer therapies. This particular form of cell death is able, through the spatiotemporally defined emission of danger signals by the dying cell, to induce an effective antitumor immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquereau-Kotula, Ewa, Habault, Justine, Kroemer, Guido, Poyet, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078289/
https://www.ncbi.nlm.nih.gov/pubmed/30080874
http://dx.doi.org/10.1371/journal.pone.0201220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078289/
https://www.ncbi.nlm.nih.gov/pubmed/30080874
http://dx.doi.org/10.1371/journal.pone.0201220

Ejemplares similares